GCP
OYST

GSA Capital Partners’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

GSA Capital Partners’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-49,422
Closed -$586K – 1935
2021
Q3 		$586K Buy
49,422
+23,853
+93% +$347K 0.06% 606
2021
Q2 		$440K Buy
+25,569
New +$486K 0.05% 715

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

GSA Capital Partners's OYST Position: Q4 2021 in Review

GSA Capital Partners sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2021, closing a stake of 49,422 shares — an estimated $586K sold.

GSA Capital Partners first reported a position in OYST in Q2 2021 and held it in 2 quarters. The position peaked at $586K in Q3 2021. 80 funds tracked by Wall St. Rank hold OYST as of Q4 2021.

  • GSA Capital Partners reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • GSA Capital Partners sold 49,422 Oyster Point Pharma, Inc. Common Stock shares in Q4 2021, an estimated $586K.
  • GSA Capital Partners first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • GSA Capital Partners's Oyster Point Pharma, Inc. Common Stock position peaked at $586K in Q3 2021.
  • 80 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2021.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.